Safeguard Scientifics, Inc. (NYSE: SFE – Get a rating) major shareholder Thomas A. Satterfield, Jr. purchased 13,646 shares of Safeguard Scientifics in a transaction that took place on Wednesday, May 25. The shares were purchased at an average cost of $3.79 per share, for a total transaction of $51,718.34. Following completion of the transaction, the insider now directly owns 476,904 shares of the company, valued at approximately $1,807,466.16. The purchase was disclosed in a legal filing with the SEC, accessible via the SEC website. Large shareholders who own more than 10% of a company’s stock are required to disclose their transactions with the SEC.
Save Scientifics stock traded at $0.06 in midday trading on Friday, reaching $4.28. 27,568 shares of the company were traded, against an average volume of 37,785. The company’s fifty-day moving average price is $4.47 and its 200-day moving average price is $5.92. Safeguard Scientifics, Inc. has a fifty-two-week low of $3.32 and a fifty-two-week high of $8.98. The company has a market capitalization of $71.16 million, a PE ratio of -86.40 and a beta of 1.05.
Several institutional investors and hedge funds have recently changed their positions in the company. Yakira Capital Management Inc. raised its position in shares of Safeguard Scientifics by 8.1% in the 1st quarter. Yakira Capital Management Inc. now owns 1,092,108 shares of the asset manager valued at $5,701,000 after buying an additional 82,158 shares last quarter. First Manhattan Co. increased its position in shares of Safeguard Scientifics by 1.5% in the 1st quarter. First Manhattan Co. now owns 992,316 shares of the asset manager valued at $5,179,000 after buying an additional 14,260 shares last quarter. Madison Avenue Partners LP increased its position in shares of Safeguard Scientifics by 48.7% in the third quarter. Madison Avenue Partners LP now owns 965,242 shares of the asset manager valued at $8,571,000 after buying an additional 316,209 shares last quarter. Contrarian Capital Management LLC raised its position in shares of Safeguard Scientifics by 6.5% in the fourth quarter. Contrarian Capital Management LLC now owns 746,542 shares of the asset manager valued at $5,487,000 after buying an additional 45,644 shares last quarter. Finally, CM Management LLC increased its position in Safeguard Scientifics shares by 4.3% in the 4th quarter. CM Management LLC now owns 600,000 shares of the asset manager valued at $4,410,000 after buying an additional 25,000 shares last quarter. 60.59% of the shares are currently held by institutional investors.
Separately, StockNews.com began covering Safeguard Scientifics in a research report on Saturday, May 21. They have placed a “holding” rating on the stock.
About Safeguard Scientifics (Get a rating)
Safeguard Scientifics, Inc is no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, spin-offs, growth and start-up financing. He initially invests in an AC series round and opportunistically in a seed round.
Get news and reviews for Safeguard Scientifics Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Safeguard Scientifics and related companies with MarketBeat.com’s free daily email newsletter.